Who should avoid GHK-CU Wilson's disease or copper metabolism disorders Active malignancies (until more research exists) Pregnancy and breastfeeding Known copper sensitivity or allergy Those unable to maintain sterile injection technique When uncertain, consult a healthcare provider familiar with peptide research
MEDICAL & LEGAL DISCLAIMER The information contained in this article is intended for licensed healthcare providers and qualified medical professionals only
Most serums show initial improvements in two to four weeks with daily use
More Than Weight Loss: GLP-1 Therapys Surprising Benefits Compounded GLP-1 medications are powerful tools for weight loss, metabolic health, and hormone balance and for some, they may even increase the likelihood of conception
So when EVOKE and EVOKE+ showed no benefit of semaglutide, it was disappointing but not surprising
however, given the high baseline prevalence of psychiatric conditions among individuals with obesity, continued vigilance, patient education, and careful screening for psychiatric history remain warranted